Showing results (271-280 of 470) with videos related to
Sort By:
Pageof 47
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.Lancet (London, England)|November 27, 2012
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialAxel Grothey, Eric Van Cutsem, Alberto Sobrero, et al.The Lancet. Oncology|July 18, 2015
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trialJosep Tabernero, Heinz-Josef Lenz, Salvatore Siena, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON StudyJosep Tabernero, Axel Grothey, Eric Van Cutsem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer StudyEric Van Cutsem, Sanne Huijberts, Axel Grothey, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 19, 2016
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)Deirdre R Pachman, Rui Qin, Drew Seisler, et al.European Journal of Cancer (Oxford, England : 1990)|January 16, 2022
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 yearsDemetris Papamichael, Guilherme S Lopes, Curt L Olswold, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant TrialsRomain Cohen, Julien Taieb, Jack Fiskum, et al.Radiology|October 24, 2006
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysisMatthew R Callstrom, Thomas D Atwell, J William Charboneau, et al.JCO Clinical Cancer Informatics|January 18, 2019
PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual PatientKrishna R Kalari, Jason P Sinnwell, Kevin J Thompson, et al.Pageof 47